Department of Radiology and Neurology, University of Michigan, Ann Arbor, MI 48105-9755, USA.
Brain. 2011 Aug;134(Pt 8):2358-65. doi: 10.1093/brain/awr139. Epub 2011 Jun 8.
Leucoaraiosis is associated with motor symptoms in otherwise normal older adults. Comorbid leucoaraiosis is predicted to contribute also to motor features in Parkinson's disease but previous studies of white matter changes in Parkinson's disease show variable results. No prior studies have compared directly the effects of both leucoaraiosis and the degree of nigrostriatal dopaminergic denervation on motor features. We investigated the effect of leucoaraiosis severity on motor impairment independent of the degree of nigrostriatal dopaminergic denervation in Parkinson's disease. Seventy-three subjects with Parkinson's disease (Hoehn and Yahr stages 1-3) underwent brain magnetic resonance and [(11)C]dihydrotetrabenazine vesicular monoamine transporter type 2 positron emission tomography imaging. Automated assessment of supratentorial fluid-attenuated inversion recovery magnetic resonance hyperintense white matter voxels was performed using cerebellar white matter as the intensity reference. White matter signal hyperintensity burden was log-transformed and normalized for brain volume. Unified Parkinson's Disease Rating Scale total and subscore ratings were assessed to determine motor impairment. Subjects receiving dopaminergic medications were examined in the clinically defined 'OFF' state. Multivariate regression analysis with measures of white matter signal hyperintensity burden and nigrostriatal denervation as independent variables demonstrated a significant overall model for total motor Unified Parkinson's Disease Rating Scale scores (F = 11.4, P < 0.0001) with significant regression effects for both white matter signal hyperintensity burden (t = 2.0, β = 0.22, P = 0.045) and striatal monoaminergic binding (t = -3.5, β = -0.38, P = 0.0008). Axial motor impairment demonstrated a robust association with white matter signal hyperintensity burden (t = 4.0, β = 0.43, P =0.0001) compared with striatal monoaminergic binding (t = -2.1, β = 0.22, P = 0.043). White matter signal hyperintensity burden regression effects for bradykinesia had borderline significance. No significant white matter signal hyperintensity burden effects were found for rigidity or tremor subscores. White matter signal hyperintensity burden was significantly higher in the subgroup with postural instability and gait difficulties compared with the tremor-predominant subgroup despite no significant differences in age or duration of disease. These findings indicate that increased white matter signal hyperintensity burden is associated with worse motor performance independent of the degree of nigrostriatal dopaminergic denervation in Parkinson's disease. Comorbid white matter disease is a greater determinant of axial motor impairment than nigrostriatal dopaminergic denervation.
脑白质疏松症与正常老年人的运动症状有关。合并存在的脑白质疏松症预计也会对帕金森病的运动特征产生影响,但先前对帕金森病患者白质变化的研究结果存在差异。以前没有研究直接比较脑白质疏松症的严重程度和黑质纹状体多巴胺能神经末梢丧失对运动特征的影响。我们研究了脑白质疏松症严重程度对帕金森病患者运动障碍的影响,而不考虑黑质纹状体多巴胺能神经末梢丧失的程度。73 名帕金森病患者(Hoehn 和 Yahr 分期 1-3)接受了脑磁共振和[(11)C]二氢四苯并嗪囊泡单胺转运体 2 正电子发射断层扫描成像。使用小脑白质作为强度参考,对幕上液衰减反转恢复磁共振高信号白质体素进行了自动评估。对脑白质信号高信号强度负担进行对数转换,并按脑容量进行归一化。使用统一帕金森病评定量表(Unified Parkinson's Disease Rating Scale,UPDRS)的总评分和亚评分评估运动障碍。接受多巴胺能药物治疗的患者在临床定义的“OFF”状态下进行检查。多元回归分析采用脑白质信号高信号强度负担和黑质纹状体神经末梢丧失作为独立变量,结果表明,总运动 UPDRS 评分的整体模型具有显著意义(F=11.4,P<0.0001),脑白质信号高信号强度负担(t=2.0,β=0.22,P=0.045)和纹状体单胺能结合(t=-3.5,β=-0.38,P=0.0008)均有显著的回归效应。与纹状体单胺能结合(t=-2.1,β=0.22,P=0.043)相比,轴向运动障碍与脑白质信号高信号强度负担(t=4.0,β=0.43,P=0.0001)有更强的关联。脑白质信号高信号强度负担对运动迟缓的回归效应具有边缘显著性。僵直和震颤亚评分无显著脑白质信号高信号强度负担效应。在姿势不稳和步态困难亚组中,脑白质信号高信号强度负担明显高于以震颤为主的亚组,尽管两组在年龄或疾病持续时间方面无显著差异。这些发现表明,脑白质信号高信号强度负担的增加与帕金森病患者的运动表现恶化有关,而与黑质纹状体多巴胺能神经末梢丧失无关。合并存在的脑白质疾病是影响运动障碍的主要因素,比黑质纹状体多巴胺能神经末梢丧失的影响更大。